Implication of the melanocortin-3 receptor in the regulation of food intake

European Journal of Pharmacology

Volumn 660, Issue 1, 2011, Pages 80-87

  Irani, Boman G ^a   Xiang, Zhimin ^a   Yarandi, Hossein N ^a   Holder, Jerry R ^a   Moore, Marcus C ^a   Bauzo, Rayna M ^a   Proneth, Bettina ^a   Shaw, Amanda M ^a   Millard, William J ^a   Chambers, James B ^b   Benoit, Stephen C ^b   Clegg, Deborah J ^b   Haskell Luevano, Carrie ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

AGRP; Energy homeostasis; Feeding; Food intake; Knockout mice; MC3R; MC4R; Melanotropin; Obesity; SHU9119

Indexed keywords

AGOUTI RELATED PROTEIN; JRH 322 18; JRH 887 9; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; FEEDING BEHAVIOR; FOOD INTAKE; KNOCKOUT GENE; METABOLIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SATIETY; TASTE AVERSION; WILD TYPE;

ALPHA-MSH; AMINO ACID SEQUENCE; ANIMALS; EATING; GENE KNOCKOUT TECHNIQUES; HUMANS; LIGANDS; MICE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4; SATIATION;

EID: 79955530102     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.10.101     Document Type: Review

References (30)

1. Atalayer, D., Robertson, K.L., Haskell-Luevano, C., Andreasen, A., Rowland, N.E., 2010. Food demand and meal size in mice with single or combined disruption of melanocortin type 3 and 4 receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R1667-R1674.
2. Benoit, S.C., Sheldon, R.J., Air, E.L., Messerschmidt, P., Wilmer, K.A., Hodge, K.M., Jones, M.B., Eckstein, D.M., McOsker, C.C., Woods, S.C., Seeley, R.J., 2003. Assessment of the aversive consequences of acute and chronic administration of the melanocortin agonist, MTII. Int. J. Obes. Relat. Metab. Disord. 27, 550-556.
3. Butler, A.A., Kesterson, R.A., Khong, K., Cullen, M.J., Pelleymounter, M.A., Dekoning, J., Baetscher, M., Cone, R.D., 2000. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141, 3518-3521. (Pubitemid 32269044)
4. Chen, A.S., Marsh, D.J., Trumbauer, M.E., Frazier, E.G., Guan, X.M., Yu, H., Rosenblum, C.I., Vongs, A., Feng, Y., Cao, L., Metzger, J.M., Strack, A.M., Camacho, R.E., Mellin, T.N., Nunes, C.N., Min, W., Fisher, J., Gopal-Truter, S., MacIntyre, D.E., Chen, H.Y., Van Der Ploeg, L.H., 2000. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26, 97-102.
5. Cowley, M.A., Pronchuk, N., Fan, W., Dinulescu, D.M., Colmers, W.F., Cone, R.D., 1999. Integration of npy, agrp, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24, 155-163. (Pubitemid 29466155)
6. Fan, W., Boston, B.A., Kesterson, R.A., Hruby, V.J., Cone, R.D., 1997. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165-168. (Pubitemid 27034218)
7. Franklin, K.B.J., Paxinos, G., 1997. The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego.
8. Greenfield, J.R., Miller, J.W., Keogh, J.M., Henning, E., Satterwhite, J.H., Cameron, G.S., Astruc, B., Mayer, J.P., Brage, S., See, T.C., Lomas, D.J., O'Rahilly, S., Farooqi, I.S., 2009. Modulation of blood pressure by central melanocortinergic pathways. N. Engl. J. Med. 360, 44-52.
9. Grieco, P., Balse, P.M., Weinberg, D., MacNeil, T., Hruby, V.J., 2000. D-amino acid scan of γ-melanocyte-stimulating hormone: importance of trp(8) on human mc3 receptor selectivity. J. Med. Chem. 43, 4998-5002.
10. Hagan, M.M., Rushing, P.A., Pritchard, L.M., Schwartz, M.W., Strack, A.M., Van Der Ploeg, L.H., Woods, S.C., Seeley, R.J., 2000. Long-term orexigenic effects of agrp-(83-132) involve mechanisms other than melanocortin receptor blockade. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R47-R52.
11. Hagan, M.M., Benoit, S.C., Rushing, P.A., Pritchard, L.M., Woods, S.C., Seeley, R.J., 2001. Immediate and prolonged patterns of agouti-related peptide-(83-132)-induced cfos activation in hypothalamic and extrahypothalamic sites. Endocrinology 142, 1050-1056. (Pubitemid 32202813)
12. Haskell-Luevano, C., Monck, E.K., 2001. Agouti-related protein (agrp) functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul. Pept. 99, 1-7.
13. Haskell-Luevano, C., Monck, E.K., Wan, Y.P., Schentrup, A.M., 2000. The agouti-related protein decapeptide (yc[crffnafc]y) possesses agonist activity at the murine melanocortin-1 receptor. Peptides 21, 683-689. (Pubitemid 30392398)
14. Haskell-Luevano, C., Cone, R.D., Monck, E.K., Wan, Y.-P., 2001. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agoutirelated protein (agrp), melanocortin agonist and synthetic peptide antagonist interaction determinants. Biochemistry 40, 6164-6179. (Pubitemid 32466321)
15. Hillebrand, J.J., Kas, M.J., Scheurink, A.J., van Dijk, G., Adan, R.A., 2006. Agrp(83-132) and SHU9119 differently affect activity-based anorexia. Eur. Neuropsychopharmacol. 16, 403-412.
16. Holder, J.R., Bauzo, R.M., Xiang, Z., Haskell-Luevano, C., 2002. Structure - activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 at the mouse melanocortin receptors: part 2 modifications at the Phe position. J. Med. Chem. 45, 3073-3081.
17. Huszar, D., Lynch, C.A., Fairchild-Huntress, V., Dunmore, J.H., Smith, F.J., Kesterson, R.A., Boston, B.A., Fang, Q., Berkemeir, L.R., Gu, W., Cone, R.D., Campfield, L.A., Lee, F., 1997. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131-141. (Pubitemid 27180337)
18. Lee, M., Kim, A., Conwell, I.M., Hruby, V., Mayorov, A., Cai, M., Wardlaw, S.L., 2008. Effects of selective modulation of the central melanocortin-3-receptor on food intake and hypothalamic pomc expression. Peptides 29, 440-447.
19. Low, M.J., Simerly, R.B., Cone, R.D., 1994. Receptors for the melanocortin peptides in the central nervous system. Curr. Opin. Endocrinol. Diabetes 1, 79-88.
20. Marks, D.L., Hruby, V., Brookhart, G., Cone, R.D., 2006. The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R). Peptides 27, 259-264. (Pubitemid 43162897)
21. Marsh, D.J., Hollopeter, G., Huszar, D., Laufer, R., Yagaloff, K.A., Fisher, S.L., Burn, P., Palmiter, R.D., 1999a. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat. Genet. 21, 119-122.
22. Marsh, D.J., Miura, G.I., Yagaloff, K.A., Schwartz, M.W., Barsh, G.S., Palmiter, R.D., 1999b. Effects of neuropeptide y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues. Brain Res. 848, 66-77. (Pubitemid 30001655)
23. McMinn, J.E., Wilkinson, C.W., Havel, P.J., Woods, S.C., Schwartz, M.W., 2000. Effect of intracerebroventricular α-msh on food intake, adiposity, c-fos induction, and neuropeptide expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R695-R703.
24. Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., Cone, R.D., 1992. The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-1251.
25. Nijenhuis, W.A., Oosterom, J., Adan, R.A., 2001. AGRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol. Endocrinol. 15, 164-171.
26. Proneth, B., Pogozheva, I.D., Portillo, F.P., Mosberg, H.I., Haskell-Luevano, C., 2008. Melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 modified at the para position of the benzyl side chain (DPhe): importance for mouse melanocortin-3 receptor agonist versus antagonist activity. J. Med. Chem. 51, 5585-5593.
27. Thiele, T.E., van Dijk, G., Yagaloff, K.A., Fisher, S.L., Schwartz, M., Burn, P., Seeley, R.J., 1998. Central infusion of melanocortin agonist MTII in rats: assessment of c-fos expression and taste aversion. Am. J. Physiol. 274, R248-R254.
28. Wessells, H., Fuciarelli, K., Hansen, J., Hadley, M.E., Hruby, V.J., Dorr, R., Levine, N., 1998. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J. Urol. 160, 389-393. (Pubitemid 29476684)
29. Wilczynski, A., Wang, X.S., Joseph, C.G., Xiang, Z., Bauzo, R.M., Scott, J.W., Sorensen, N.B., Shaw, A.M., Millard, W.J., Richards, N.G., Haskell-Luevano, C., 2004a. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands. J. Med. Chem. 47, 2194-2207.
30. Wilczynski, A.M., Wang, X.S., Bauzo, R.M., Xiang, Z., Shaw, A.M., Millard, W.J., Richards, N.G.J., Edison, A.S., Haskell-Luevano, C., 2004b. Structural characterization of a potent (Cys101-Cys119, Cys110-Cys117) bicyclic agouti-related protein (AGRP) melanocortin receptor antagonist. J. Med. Chem. 47, 5662-5673.